Login / Signup

Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction?

Kinga KrzyżowskaAureliusz KolonkoPiotr GizaJerzy ChudekAndrzej Więcek
Published in: BioMed research international (2018)
Initial tacrolimus dose reduction should be considered in older, overweight, or obese kidney transplant recipients and in subjects with anti-HCV antibodies. Moreover, dose reduction of tacrolimus is especially important in patients with coexisting multiple risk factors.
Keyphrases
  • risk factors
  • weight loss
  • physical activity
  • hepatitis c virus
  • adipose tissue
  • metabolic syndrome
  • type diabetes
  • middle aged
  • human immunodeficiency virus
  • weight gain
  • community dwelling
  • obese patients